110 related articles for article (PubMed ID: 16630171)
1. Paraoxonase-1 Q192R polymorphism and risk of sporadic amyotrophic lateral sclerosis.
Slowik A; Tomik B; Partyka D; Turaj W; Pera J; Dziedzic T; Szermer P; Figlewicz DA; Szczudlik A
Clin Genet; 2006 Apr; 69(4):358-9. PubMed ID: 16630171
[No Abstract] [Full Text] [Related]
2. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.
Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH
Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314
[TBL] [Abstract][Full Text] [Related]
3. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis.
Morahan JM; Yu B; Trent RJ; Pamphlett R
Neurotoxicology; 2007 May; 28(3):532-40. PubMed ID: 17204329
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase gene polymorphisms and sporadic ALS.
Slowik A; Tomik B; Wolkow PP; Partyka D; Turaj W; Malecki MT; Pera J; Dziedzic T; Szczudlik A; Figlewicz DA
Neurology; 2006 Sep; 67(5):766-70. PubMed ID: 16822965
[TBL] [Abstract][Full Text] [Related]
5. Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients.
van Blitterswijk M; Blokhuis A; van Es MA; van Vught PW; Rowicka PA; Schelhaas HJ; van der Kooi AJ; de Visser M; Veldink JH; van den Berg LH
Neurobiol Aging; 2012 Aug; 33(8):1845.e1-3. PubMed ID: 22330174
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.
Balcerzyk A; Zak I; Krauze J
Arch Med Res; 2007 Jul; 38(5):545-50. PubMed ID: 17560461
[TBL] [Abstract][Full Text] [Related]
7. The paraoxonase L55M and Q192R gene polymorphisms and myocardial infarction in a Tunisian population.
Kallel A; Sediri Y; Sbaï MH; Mourali MS; Feki M; Elasmi M; Taieb SH; Sanhaji H; Souheil O; Mechmeche R; Jemaa R; Kaabachi N
Clin Biochem; 2010 Dec; 43(18):1461-3. PubMed ID: 20833162
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of PON polymorphisms with sporadic ALS in an Italian population.
Ricci C; Battistini S; Cozzi L; Benigni M; Origone P; Verriello L; Lunetta C; Cereda C; Milani P; Greco G; Patrosso MC; Causarano R; Caponnetto C; Giannini F; Corbo M; Penco S
Neurobiol Aging; 2011 Mar; 32(3):552.e7-13. PubMed ID: 20381198
[TBL] [Abstract][Full Text] [Related]
9. Frequency of a tau genotype in amyotrophic lateral sclerosis.
Münch C; Prechter F; Xu R; Linke P; Prudlo J; Kuzma M; Kwiecinski H; Ludolph AC; Meyer T
J Neurol Sci; 2005 Sep; 236(1-2):13-6. PubMed ID: 16005901
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase genes and susceptibility to ALS.
Greenberg DA; Stewart WC; Rowland LP
Neurology; 2009 Jul; 73(1):11-2. PubMed ID: 19439719
[No Abstract] [Full Text] [Related]
11. VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients.
Zhang Y; Zhang H; Fu Y; Song H; Wang L; Zhang J; Fan D
Amyotroph Lateral Scler; 2006 Jun; 7(2):119-22. PubMed ID: 16753977
[TBL] [Abstract][Full Text] [Related]
12. Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis.
Coppedè F; Mancuso M; Lo Gerfo A; Carlesi C; Piazza S; Rocchi A; Petrozzi L; Nesti C; Micheli D; Bacci A; Migliore L; Murri L; Siciliano G
Neurosci Lett; 2007 Jun; 420(2):163-8. PubMed ID: 17531381
[TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
Stevens VL; Rodriguez C; Talbot JT; Pavluck AL; Thun MJ; Calle EE
Prostate; 2008 Sep; 68(12):1336-40. PubMed ID: 18500687
[TBL] [Abstract][Full Text] [Related]
14. Ciliary neurotrophic factor null alleles are not a risk factor for Charcot-Marie-Tooth disease, hereditary neuropathy with pressure palsies and amyotrophic lateral sclerosis.
Van Vught PW; Van Wijk J; Bradley TE; Plasmans D; Jakobs ME; Veldink JH; de Jong JM; Van den Berg LH; Baas F
Neuromuscul Disord; 2007 Dec; 17(11-12):964-7. PubMed ID: 17651970
[TBL] [Abstract][Full Text] [Related]
15. Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis?
Ghezzi S; Del Bo R; Scarlato M; Nardini M; Carlesi C; Prelle A; Corti S; Mancuso M; Briani C; Siciliano G; Murri L; Bresolin N; Comi GP
Neurobiol Aging; 2009 May; 30(5):842-4. PubMed ID: 17888545
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis.
Daoud H; Belzil V; Desjarlais A; Camu W; Dion PA; Rouleau GA
Arch Neurol; 2010 Apr; 67(4):516-7. PubMed ID: 20385924
[No Abstract] [Full Text] [Related]
18. Serum paraoxonase and arylesterase activities in patients with lacunar infarction: a case control study.
Moghtaderi A; Hashemi M; Dabiri S; Moazeni-Roodi A; Hosseini M
Clin Biochem; 2011 Mar; 44(4):288-92. PubMed ID: 21167145
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke.
Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O
Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578
[TBL] [Abstract][Full Text] [Related]
20. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden.
Valdmanis PN; Kabashi E; Dyck A; Hince P; Lee J; Dion P; D'Amour M; Souchon F; Bouchard JP; Salachas F; Meininger V; Andersen PM; Camu W; Dupré N; Rouleau GA
Neurology; 2008 Aug; 71(7):514-20. PubMed ID: 18695162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
